Phase I trial of ZD9331, a non-polyglutamatable thymidylate synthase inhibitor given as a 5-day continuous infusion every 3 weeks

✍ Scribed by Trigo, J.; Rees, C.; Beale, P.; Mitchell, F.; Jackman, A.; Smith, R.; Hutchison, M.; Smith, M.; Judson, I.

• Book ID: 123294756
• Publisher: Elsevier Science
• Year: 1999
• Tongue: English
• Weight: 159 KB
• Volume: 35
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(99)81569-X